AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gould, M. N.
Right arrow Articles by Elson, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gould, M. N.
Right arrow Articles by Elson, C. E.
Agricola
Right arrow Articles by Gould, M. N.
Right arrow Articles by Elson, C. E.

American Journal of Clinical Nutrition, Vol 53, 1068S-1070S, Copyright © 1991 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors

MN Gould, JD Haag, WS Kennan, MA Tanner and CE Elson
Department of Human Oncology, University of Wisconsin-Madison 53792.

Two forms of vitamin E, tocopherol and tocotrienol, were tested for chemopreventive activity in two chemically induced rat mammary-tumor models. When mammary tumors were induced by 7,12- dimethylbenz(a)anthracene (DMBA, 50 mg/kg), only the tocotrienol group had a statistically significant increase in tumor latency. There was no effect of either compound on tumor multiplicity. When tumors were induced by N-nitrosomethylurea (NMU, 30 mg/kg), neither analogue of vitamin E modified latency, whereas tocotrienol increased tumor multiplicity. In summary, neither vitamin analog had a major impact on mammary-tumor development after tumor induction with either DMBA or NMU.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. S. Ahn, G. Sethi, K. Krishnan, and B. B. Aggarwal
{gamma}-Tocotrienol Inhibits Nuclear Factor-{kappa}B Signaling Pathway through Inhibition of Receptor-interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of Apoptosis
J. Biol. Chem., January 5, 2007; 282(1): 809 - 820.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. S. McIntyre, K. P. Briski, A. Gapor, and P. W. Sylvester
Antiproliferative and Apoptotic Effects of Tocopherols and Tocotrienols on Preneoplastic and Neoplastic Mouse Mammary Epithelial Cells
Experimental Biology and Medicine, September 1, 2000; 224(4): 292 - 301.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition